Amarin Corporation PLC (AMRN) Reports Second Quarter 2013 Financial Results and Provides Update on Operations
8/9/2013 9:00:47 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 8, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for Q2, the quarter ended June 30, 2013, and provided an update on company operations.
Help employers find you! Check out all the jobs and post your resume.
comments powered by